Novel Bis(2-cyanoacrylamide) Linked to Sulphamethoxazole: Synthesis, DNA Interaction, Anticancer, ADMET, Molecular Docking, and DFT Studies.
Autor: | Ragheb MA; Department of Chemistry (Biochemistry Division), Faculty of Science, Cairo University, Giza, 12613, Egypt., Mohamed FG; Department of Chemistry (Biochemistry Division), Faculty of Science, Cairo University, Giza, 12613, Egypt., Diab HM; Department of Chemistry, Faculty of Science, Cairo University, Giza, 12613, Egypt., Ragab MS; Department of Chemistry, Faculty of Science, Cairo University, Giza, 12613, Egypt., Emara M; Center for Aging and Associated Diseases, Zewail City of Science, Technology and innovation, 12578-, Giza, Egypt., Elwahy AHM; Department of Chemistry, Faculty of Science, Cairo University, Giza, 12613, Egypt., Abdelhamid IA; Department of Chemistry, Faculty of Science, Cairo University, Giza, 12613, Egypt., Soliman MH; Department of Chemistry (Biochemistry Division), Faculty of Science, Cairo University, Giza, 12613, Egypt. |
---|---|
Jazyk: | angličtina |
Zdroj: | Chemistry & biodiversity [Chem Biodivers] 2024 Apr; Vol. 21 (4), pp. e202301341. Date of Electronic Publication: 2024 Mar 08. |
DOI: | 10.1002/cbdv.202301341 |
Abstrakt: | In the light of advancement and potential extensive use of medication design and therapy, new bis(cyanoacrylamides) incorporating sulphamethoxazole derivatives (7 a-7 f) were synthesized and confirmed by different spectral tools. In vitro anticancer activity towards different human cancer cells (HCT116, MDA-MB-231 and A549) was assessed using MTT assay. Among all derivatives, 4C- and 6C-spacer derivatives (7 e and 7 f) had the most potent growth inhibitory activities against HCT116 cells with IC (© 2024 Wiley‐VHCA AG, Zurich, Switzerland.) |
Databáze: | MEDLINE |
Externí odkaz: |